Cognex director granted and converts restricted stock units

COGNEX CORP director Sachin Lawande reported equity awards and an RSU conversion.

Rhea-AI Filing Summary

COGNEX CORP director Sachin Lawande reported equity awards and an RSU conversion. On February 18, 2026, 8,324 restricted stock units were exercised or converted into 8,324 shares of common stock at a stated price of $0.00 per share, leaving 25,518 common shares held directly.

On February 17, 2026, Lawande received a grant of 4,817 restricted stock units, each representing a contingent right to one share of Cognex common stock. Footnotes state that one RSU grant vests 100% on the first anniversary of the February 18, 2025 grant date, and another vests 100% on the first anniversary of the February 17, 2026 grant date.

Insider Trade Summary

8,324 shares exercised/converted

Exercise 4 txns

Insider Lawande Sachin

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	8,324	$0.00	$0.00
Exercise	Common Stock	8,324	$0.00	$0.00
Grant/Award	Restricted Stock Unit	4,817	$0.00	$0.00
holding	Restricted Stock Unit	--	--	--

Holdings After Transaction: Restricted Stock Unit — 7,730 contracts for 2,913 underlying shares (Direct); Common Stock — 25,518 shares (Direct)

Footnotes (3)

1. F1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
2. F2. The restricted stock units vest 100% on the first anniversary of the grant date (February 18, 2025).
3. F3. The restricted stock units vest 100% on the first anniversary of the grant date (February 17, 2026).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cognex (CGNX) director Sachin Lawande report in this Form 4?

Sachin Lawande reported the acquisition of equity through restricted stock units and their conversion. The filing shows an 8,324-unit RSU exercise into common stock and a separate 4,817-unit RSU grant, all held as direct beneficial ownership in Cognex common shares and RSUs.

How many Cognex (CGNX) shares were acquired through RSU conversion?

The filing shows 8,324 restricted stock units were exercised or converted into 8,324 shares of Cognex common stock. The stated price per share is $0.00, reflecting a stock-based award rather than an open-market purchase, and raises Lawande’s direct common stock holdings to 25,518 shares.

What new restricted stock units did Sachin Lawande receive from Cognex (CGNX)?

Sachin Lawande received a grant of 4,817 restricted stock units on February 17, 2026. Each restricted stock unit represents a contingent right to receive one Cognex common share, increasing his derivative equity holdings before future vesting and any subsequent conversions into common stock.

When do the reported Cognex (CGNX) restricted stock units vest?

One RSU grant vests 100% on the first anniversary of its February 18, 2025 grant date. Another RSU grant vests 100% on the first anniversary of the February 17, 2026 grant date, subject to continued service or other plan conditions described in Cognex’s equity program.

How many Cognex (CGNX) common shares does Sachin Lawande hold after these transactions?

After the February 18, 2026 RSU conversion, Lawande directly holds 25,518 shares of Cognex common stock. He also holds 4,817 restricted stock units from the February 17, 2026 grant, which provide a contingent right to receive additional Cognex shares upon vesting.

Were there any open-market buys or sells in this Cognex (CGNX) Form 4?

The Form 4 shows no open-market purchases or sales. All reported activity involves a grant of restricted stock units and an exercise or conversion of RSUs into common stock, both treated as equity compensation events rather than discretionary trading in Cognex shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 04:37 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lawande Sachin

(Last) (First) (Middle)

ONE VISION DRIVE

(Street)

NATICK MA 01760

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COGNEX CORP [ CGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		M		8,324	A	$0.0	25,518	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0.0(1)	02/18/2026		M			8,324	02/18/2026(2)	02/18/2026	Common Stock	8,324	$0.0	0	D
Restricted Stock Unit	(1)	02/17/2026		A		4,817		02/17/2027(3)	02/17/2027	Common Stock	4,817	$0.0	4,817	D
Restricted Stock Unit	$0.0							02/21/2024	02/21/2026	Common Stock	2,913		2,913	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.

2. The restricted stock units vest 100% on the first anniversary of the grant date (February 18, 2025).

3. The restricted stock units vest 100% on the first anniversary of the grant date (February 17, 2026).

	Sachin Lawande	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.